EIDAR: Use of Ultrasound for Early Identification of Patients at Risk of Swallowing Disorders Acquired in the ICU

Sponsor
Centre Hospitalier Universitaire Dijon (Other)
Overall Status
Not yet recruiting
CT.gov ID
NCT05922085
Collaborator
(none)
100
1
1
26
3.8

Study Details

Study Description

Brief Summary

Swallowing disorders (SD) are particularly common after extubation in the ICU and may be associated with an increased risk of lung disease, increased length of hospital stay, and a higher risk of early reintubation. In contrast, early detection of SDs has been shown to be associated with a decrease in these complications. Thus, there is a need for rapid and reliable assessment of SDs in ICU patients before the withdrawal of mechanical ventilation.

Videofluoroscopy (VFS) and nasofibroscopy (NF) are the gold standard examinations for diagnosing SD. However, these two examinations are not feasible in intubated patients.

In this context, ultrasound appears to be a promising alternative to identify patients at risk of SD after extubation. This examination can be performed at the intubated patient's bedside and can be used evaluate the mobility of the structures involved in swallowing. Many studies have already shown the interest of ultrasound in the evaluation of SD but none has focused on intubated patients under respiratory assistance.

The objective of the present study is to evaluate the value of ultrasound in identifying patients at risk of presenting SD after extubation.

This monocentric study will take place in the Intensive Care Unit (ICU) of the Dijon University Hospital. The duration of participation in this research will be equal to the length of stay in the ICU. During their stay, patients will undergo ultrasound and nasofibroscopy. Information on the characteristics of the ICU stay will be collected at discharge.

Condition or Disease Intervention/Treatment Phase
  • Other: Ultrasound
  • Other: nasofibroscopie
N/A

Study Design

Study Type:
Interventional
Anticipated Enrollment :
100 participants
Allocation:
N/A
Intervention Model:
Single Group Assignment
Masking:
None (Open Label)
Primary Purpose:
Prevention
Official Title:
Use of Ultrasound for Early Identification of Patients at Risk of Swallowing Disorders Acquired in the ICU
Anticipated Study Start Date :
Jun 1, 2023
Anticipated Primary Completion Date :
Aug 1, 2025
Anticipated Study Completion Date :
Aug 1, 2025

Arms and Interventions

Arm Intervention/Treatment
Experimental: patient under mechanical ventilation for at least 7 days

Other: Ultrasound
performed within 3 hours prior to extubation

Other: nasofibroscopie
performed within 24 to 36 hours after extubation

Outcome Measures

Primary Outcome Measures

  1. rate of swallowing disorders [Within 24 to 36 hours of extubation]

    assessed by the Penetration-Aspiration Scale (PAS)

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
All
Accepts Healthy Volunteers:
No
Inclusion Criteria:
Patient:
  • Major

  • On mechanical ventilation for at least 7 days

  • Affiliated to national health insurance

Exclusion Criteria:
Patient:
  • Under legal protection (curatorship, guardianship, safeguard of justice)

  • Pregnant, parturient or breastfeeding woman

  • Refusal to participate by the patient or their proxy (or an immediate family member)

  • Cognitive disorders incompatible with the understanding of instructions

  • Previously diagnosed swallowing disorders

  • With a neurological condition at the origin of the SD (stroke, ALS...)

  • Treated for a lesion of the aerodigestive tract (by surgery, radiotherapy or radio-chemotherapy)

  • presence of wounds or dressings on the areas to be evaluated that prevent ultrasound measurements

  • Patient for whom a decision to limit or stop life support treatments has been taken collegially within the intensive care unit

  • With one or more contraindications to performing NF:

  • Anatomical features not compatible with NF: mainly deviation of the nasal septum.

  • Risk of significant otorhinolaryngological bleeding

Contacts and Locations

Locations

Site City State Country Postal Code
1 Chu Dijon Bourgogne Dijon France

Sponsors and Collaborators

  • Centre Hospitalier Universitaire Dijon

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Centre Hospitalier Universitaire Dijon
ClinicalTrials.gov Identifier:
NCT05922085
Other Study ID Numbers:
  • PINEDA APPARA 2022
First Posted:
Jun 28, 2023
Last Update Posted:
Jun 28, 2023
Last Verified:
Jun 1, 2023
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Additional relevant MeSH terms:

Study Results

No Results Posted as of Jun 28, 2023